Recent advance in experimental study of cerebral ischemia treated by vascular endothelial growth factor.
- Author:
Shi-fang LI
1
;
Ren-zhi WANG
;
Gui-lin LI
Author Information
1. Department of Neurosurgery, PUMC Hospital, CAMS and PUMC, Beijing 100730, China.
- Publication Type:Journal Article
- MeSH:
Animals;
Brain Ischemia;
drug therapy;
physiopathology;
Dose-Response Relationship, Drug;
Neovascularization, Physiologic;
drug effects;
Nerve Regeneration;
drug effects;
Neuroprotective Agents;
pharmacology;
Vascular Endothelial Growth Factor A;
administration & dosage;
pharmacology
- From:
Acta Academiae Medicinae Sinicae
2005;27(1):115-119
- CountryChina
- Language:Chinese
-
Abstract:
Vascular endothelial growth factor (VEGF) has been found to be the most powerful angiogenic factor. Studies have shown that cerebral ischemia and hypoxia stimulate the expressions of VEGF and its receptors in the brain, while exogenous VEGF promotes the formation of new blood vessels in the ischemic brain penumbra, and reduce the volume of cerebral infarction. The effect of VEGF on cerebral ischemia was previously explained the mechanism that VEGF had a specific mitogenetic roles in cerebral endothelial cells and thus promoted neovascularization; however recent evidence has shown that VEGF also has direct effects on neural and glial cells. Its multiple protection roles on central nervous system involve vascularization, neurogenesis, direct neurotrophic and neuroprotective effect, as well as antiapoptosis effect, especially when brain ischemia occurs. Further elucidation of these mechanisms on central nervous system may serve as a key procedure in understanding the main aspects of neural repair and neural protection, and develop effective therapeutic measures for intervention in stroke.
